KCT0004079招募中未知
Effects and Safety of Intranasal Phototherapy for Allergic Rhinitis: Study Protocol for a Single-center, Randomized, Parallel (acupuncture-controlled), Open-label, Investigator-initiated, Pilot Study.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Presence of two or more symptoms of allergic rhinitis(nasal congestion, rhinorrhea, nasal itching and sneezing) and Positive reaction to an allergen in multiple allergen simultaneous test
排除标准
- •1) Patients who take any medication as follows or who can’t stop taking medication which is unsuitable for this clinical trail.(But they can be enrolled in this trial after the minimum Wash-out period as suggested, before Visit2.)
- •? anti-histamine/H1 blockers within the last 7days
- •? corticosteroids(intranasal) within the last 14days
- •? corticosteroids(systemic) within the last 30days
- •? anti-cholinergic drug within the last 7days
- •? anti-leukotriene drug within the last 4weeks
- •? decongestants within the last 3days
- •? tricyclic antidepressants, phenothiazines within the last 14days
- •? non-steroidal analgesics within the last 14days
- •? Others (inappropriate medications)
- •2) Korean Medicine treatment(herbal medicine, acupuncture, moxibustion, cupping, etc) to treat allergic rhinitis within the last 14days
- •3) Laser therapy to treat allergic rhinitis within the last 14days
- •4) Patients who have had treatments due to acute upper respiratory infections or sinusitis, within the last 4weeks
- •5) Non-allergic rhinitis such as vasomotor, infectious, drug-induced rhinitis, or other severe nasal illness
- •6) Anatomical obstruction or deformities of the nasal cavity or nasal surgery within the past 6 months
- •7) Malignant neoplasm, anemia, active pulmonary tuberculosis, infection or other severe systemic disease
- •8) Past history of active respiratory disease like asthma
- •9) Immunotherapy or systemic corticosteroids therapy within the last 5 years
- •10) hypersensitivity reaction to phototherapy or taking related drugs
- •11) scar on the irradiation(or acupuncture) spot
- •12) Pregnancy, planning a pregnancy or breast-feeding
- •13) Participation in other clinical trials within the last 1 month
- •14) Difficulties in enrolling this trial or receiving treatment
- •15) Ineligibility for participation as judged by the investigator
研究者
相似试验
进行中（未招募）
不适用
Effects and Safety of Intranasal Phototherapy for Allergic RhinitisKCT0003253Woosuk University40
已完成
不适用
Safety and efficacy of photodynamic therapy using ME2906 and PNL6405GST for gastric cancer in patients who cannot undergo surgery or endoscopic resectioGastric cancerJPRN-UMIN000032398Gunma University Hospital18
已完成
不适用
The efficacy and safety of photodynamic therapy for central serous chorioretinopathyCentral serous chorioretinopathyJPRN-UMIN000022126Kyoto Prefectual Univercity of Medicine20
尚未招募
2 期
Safety and efficacy of photodynamic therapy (with riboflavin as sensitizer) for treatment of malaria in adult Nigerian populatioMalariaPACTR201912897645869Future Minds Development Initiative200
尚未招募
2 期
Efficacy of Photodynamic therapy with topical Indocyanine green in the treatment of Keloidal lesionsHypertrophic scarIRCT20201221049780N1Mashhad University of Medical Sciences15